How Do You Spell GADOPENTETATE DIMEGLUMINE?

Pronunciation: [ɡˈadə͡ʊpəntˌɪte͡ɪt dˈa͡ɪmɡluːmˌa͡ɪn] (IPA)

Gadopentetate dimeglumine is a radiographic contrast agent used in medical imaging procedures. Its lengthy name is derived from its chemical composition, which includes the elements gadolinium, pentetic acid, and two molecules of meglumine. The word "gadopentetate" is pronounced as /ɡædəʊˈpɛntɪteɪt/, with stress on the second syllable. "Dimeglumine" is pronounced as /daɪˈmɛɡljuːmiːn/, with stress on the first syllable. The accurate spelling of this word can be challenging due to its length and complexity, but it is critical to ensure proper administration and patient safety.

GADOPENTETATE DIMEGLUMINE Meaning and Definition

1. Gadopentetate dimeglumine is a complex medical term used to refer to a contrast agent used in diagnostic imaging techniques like magnetic resonance imaging (MRI). It is commonly known by its brand name, Magnevist.

   Gadopentetate dimeglumine is a paramagnetic compound that contains gadolinium, an element used to enhance the visibility of certain tissues and organs during MRI scans. It is made up of gadolinium-DTPA (gadopentetate) and a meglumine salt (dimeglumine).

   When administered intravenously, gadopentetate dimeglumine travels through the bloodstream and accumulates in specific tissues and organs where increased vascularity or abnormal blood-brain barrier integrity is present. Its paramagnetic properties enable it to affect the magnetic field generated during an MRI, enhancing the contrast between healthy and abnormal tissues.

   By highlighting specific areas of interest, gadopentetate dimeglumine assists radiologists and healthcare professionals in the accurate interpretation of MRI scans. It may be used to improve visualization of the brain, spine, liver, breast, and other parts of the body.

   It is important to note that gadopentetate dimeglumine should be used with caution in patients with renal impairment, as it has the potential to cause a serious condition called nephrogenic systemic fibrosis (NSF). Therefore, healthcare professionals must consider the patient's renal function and weigh the risks and benefits before administering this contrast agent.

Common Misspellings for GADOPENTETATE DIMEGLUMINE

• fadopentetate dimeglumine
• vadopentetate dimeglumine
• badopentetate dimeglumine
• hadopentetate dimeglumine
• yadopentetate dimeglumine
• tadopentetate dimeglumine
• gzdopentetate dimeglumine
• gsdopentetate dimeglumine
• gwdopentetate dimeglumine
• gqdopentetate dimeglumine
• gasopentetate dimeglumine
• gaxopentetate dimeglumine
• gacopentetate dimeglumine
• gafopentetate dimeglumine
• garopentetate dimeglumine
• gaeopentetate dimeglumine
• gadipentetate dimeglumine
• gadkpentetate dimeglumine
• gadlpentetate dimeglumine
• gadppentetate dimeglumine